Skip to main content

Market Overview

Morgan Keegan Analyzes Publicly Traded Healthcare REITs (HCP, HCN, VTR, NHP)

Share:

In a report released this morning, Morgan Keegan provides an analysis of publicly traded healthcare REITs with respect to FFO/FAD, investment composition, and asset coverage ratios.

“Since our last report, we have seen four noteworthy large deals: HCP, Inc.'s (NYSE: HCP) $6.1 billion acquisition of the real estate of HCR Manor Care, Health Care REIT Inc.'s (NYSE: HCN) $1.3 billion entry into three senior housing operating joint ventures, Ventas Inc.'s (NYSE: VTR) $7.4 billion (announced value, currently $7.1-$7.2 billion, we estimate) acquisition of Nationwide Health Properties Inc. (NYSE: NHP), and Health Care REIT's $2.4 billion acquisition of real estate operated by Genesis HealthCare,” Morgan Keegan writes.

“The ‘big three' getting larger via pricey deals has been the headline of late. For the sector as a whole, though, we believe that the biggest theme to emerge is the need to accelerate FFO growth in order for healthcare REIT shares to compete with those of REITs investing in recovering cyclical assets.”

HCP closed Tuesday at $37.57; Ventas closed at $52.37; Health Care REIT closed at $51.75; and Nationwide Health Properties closed at $40.79.

 

Related Articles (HCN + HCP)

View Comments and Join the Discussion!

Posted-In: HCP Health Care REIT Morgan Keegan nationwide health properties VentasAnalyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com